176 related articles for article (PubMed ID: 29596815)
1. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
Verhoven SM; Groszek JJ; Fissell WH; Seegmiller A; Colby J; Patel P; Verstraete A; Shotwell M
Clin Chim Acta; 2018 Jul; 482():60-64. PubMed ID: 29596815
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
Connor MJ; Salem C; Bauer SR; Hofmann CL; Groszek J; Butler R; Rehm SJ; Fissell WH
Antimicrob Agents Chemother; 2011 Feb; 55(2):557-60. PubMed ID: 21115798
[TBL] [Abstract][Full Text] [Related]
3. A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.
Veillette JJ; Winans SA; Forland SC; Maskiewicz VK
J Pharm Biomed Anal; 2016 Nov; 131():80-86. PubMed ID: 27529601
[TBL] [Abstract][Full Text] [Related]
4. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
[TBL] [Abstract][Full Text] [Related]
5. A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
Popowicz ND; O'Halloran SJ; Fitzgerald D; Lee YCG; Joyce DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():58-66. PubMed ID: 29505960
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
Marselos SC; Archontaki HA
J Pharm Biomed Anal; 2002 Jul; 29(5):787-93. PubMed ID: 12093510
[TBL] [Abstract][Full Text] [Related]
7. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
Arzuaga A; Isla A; Gascón AR; Maynar J; Martín A; Solinís MA; Toral D; Pedraz JL
Biomed Chromatogr; 2005 Oct; 19(8):570-8. PubMed ID: 15828066
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
[TBL] [Abstract][Full Text] [Related]
9. New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.
Trittler R; Ehrlich M; Galla TJ; Horch RE; Kümmerer K
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):127-32. PubMed ID: 12113978
[TBL] [Abstract][Full Text] [Related]
10. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis.
Dalla Costa T; Nolting A; Kovar A; Derendorf H
J Antimicrob Chemother; 1998 Dec; 42(6):769-78. PubMed ID: 10052901
[TBL] [Abstract][Full Text] [Related]
11. Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients.
Zander J; Döbbeler G; Nagel D; Scharf C; Huseyn-Zada M; Jung J; Frey L; Vogeser M; Zoller M
Int J Antimicrob Agents; 2016 Oct; 48(4):435-9. PubMed ID: 27476810
[TBL] [Abstract][Full Text] [Related]
12. An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.
Xia CH; Xiong YQ; Wang GJ
Biomed Chromatogr; 2007 Jul; 21(7):680-6. PubMed ID: 17385803
[TBL] [Abstract][Full Text] [Related]
13. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
Sörgel F; Kinzig M
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():39-60. PubMed ID: 8383655
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
Cies JJ; Shankar V; Schlichting C; Kuti JL
Pediatr Infect Dis J; 2014 Feb; 33(2):168-73. PubMed ID: 23907263
[TBL] [Abstract][Full Text] [Related]
15. A new HPLC-MS/MS analytical method for quantification of tazobactam, piperacillin, and meropenem in human plasma.
Krnáč D; Reiffová K; Rolinski B
J Sep Sci; 2021 Jul; 44(14):2744-2753. PubMed ID: 33988308
[TBL] [Abstract][Full Text] [Related]
16. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
Jung B; Mahul M; Breilh D; Legeron R; Signe J; Jean-Pierre H; Uhlemann AC; Molinari N; Jaber S
Crit Care Med; 2017 May; 45(5):e470-e478. PubMed ID: 28240688
[TBL] [Abstract][Full Text] [Related]
17. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
[TBL] [Abstract][Full Text] [Related]
18. A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam.
Martínková J; Malbrain ML; Havel E; Šafránek P; Bezouška J; Kaška M
Anaesthesiol Intensive Ther; 2016; 48(1):23-8. PubMed ID: 26588478
[TBL] [Abstract][Full Text] [Related]
19. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
Tomaselli F; Dittrich P; Maier A; Woltsche M; Matzi V; Pinter J; Nuhsbaumer S; Pinter H; Smolle J; Smolle-Jüttner FM
Br J Clin Pharmacol; 2003 Jun; 55(6):620-4. PubMed ID: 12814459
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.
Nicasio AM; VanScoy BD; Mendes RE; Castanheira M; Bulik CC; Okusanya OO; Bhavnani SM; Forrest A; Jones RN; Friedrich LV; Steenbergen JN; Ambrose PG
Antimicrob Agents Chemother; 2016 Apr; 60(4):2075-80. PubMed ID: 26787689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
